The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats

Journal of Lipid Research

Volumn 47, Issue 9, 2006, Pages 2042-2048

  Thomàs Moyà, Elena ^a   Gianotti, Magdalena ^a   Proenza, Ana M ^a   Lladó, Isabel ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Aging; Apolipoprotein A I; Apolipoprotein J; Gender; Lipid peroxidation

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

AGING; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CALORIC RESTRICTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SHAM FEEDING;

AGING; ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CALORIC RESTRICTION; CLUSTERIN; FEMALE; LIPID PEROXIDES; LIPIDS; LIPOPROTEINS, HDL; MALE; RATS; SEX FACTORS;

EID: 33748743734     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600215-JLR200     Document Type: Article

References (41)

1. Yu, B. P., and H. Y. Chung. 2006. Adaptive mechanisms to oxidative stress during aging. Mech. Ageing Dev. 127: 436-443.
2. Yu, B. P. 1996. Aging and oxidative stress: modulation by dietary restriction. Free Radic. Biol. Med. 21: 651-668.
3. Stocker, R., and J. F. Keaney, Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84: 1381-1478.
4. Aronow, W. S. 2004. Lipids and the elderly. Rev. Endocr. Metab. Disord. 5: 359-364.
5. Nakamura, Y. K., and S. T. Omaye. 2004. Age-related changes of serum lipoprotein oxidation in rats. Life Sci. 74: 1265-1275.
6. Walzem, R. L., S. Watkins, E. N. Frankel, R. J. Hansen, and J. B. German. 1995. Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc. Natl. Acad. Sci. USA. 92: 7460-7464.
7. Merry, B. J. 2005. Dietary restriction in rodents - delayed or retarded ageing? Mech. Ageing Dev. 126: 951-959.
8. Le Bourg, E. 2005. [Is caloric restriction a means of delaying ageing and increasing longevity?] Presse Med. 34: 121-127.
9. Choi, Y. S., S. Goto, I. Ikeda, and M. Sugano. 1988. Age-related changes in lipid metabolism in rats: the consequence of moderate food restriction. Biochim. Biophys. Acta. 963: 237-242.
10. Fontana, L., T. E. Meyer, S. Klein, and J. O. Holloszy. 2004. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl. Acad. Sci. USA. 101: 6659-6663.
11. Merry, B. J. 2002. Molecular mechanisms linking calorie restriction and longevity. Int. J. Biochem. Cell Biol. 34: 1340-1354.
12. Yang, H., M. Shi, J. Story, A. Richardson, and Z. Guo. 2004. Food restriction attenuates age-related increase in the sensitivity of endothelial cells to oxidized lipids. J. Gerontol. A Biol. Sci. Med. Sci. 59: 316-323.
13. Kelso, G. J., W. D. Stuart, R. J. Richter, C. E. Furlong, T. C. Jordan-Starck, and J. A. Harmony. 1994. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry. 33: 832-839.
14. Sorenson, R. C., C. L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B. N. La Du. 1999. Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler. Thromb. Vasc. Biol. 19: 2214-2225.
15. Mackness, M., P. Durrington, and B. Mackness. 2004. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Curr. Opin. Lipidol. 15: 399-404.
16. Primo-Parmo, S. L., R. C. Sorenson, J. Teiber, and B. N. La Du. 1996. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33: 498-507.
17. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. La Du, K. F. Faull, A. M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96: 2882-2891.
18. Aviram, M., M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. La Du. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101: 1581-1590.
19. Rosenblat, M., L. Gaidukov, O. Khersonsky, J. Vaya, R. Oren, D. S. Tawfik, and M. Aviram. 2006. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J. Biol. Chem. 281: 7657-7665.
20. Mackness, B., P. Durrington, P. McElduff, J. Yarnell, N. Azam, M. Watt, and M. Mackness. 2003. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation. 107: 2775-2779.
21. Deakin, S., I. Leviev, M. Gomaraschi, L. Calabresi, G. Franceschini, and R. W. James. 2002. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem. 277: 4301-4308.
22. Thomas-Moya, E., M. Gianotti, I. Llado, and A. M. Proenza. 2006. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity. J. Nutr. Biochem. 17: 197-203.
23. Costa, L. G., A. Vitalone, T. B. Cole, and C. E. Furlong. 2005. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69: 541-550.
24. Mackness, B., P. N. Durrington, and M. I. Mackness. 1998. Lack of protection against oxidative modification of LDL by avian HDL. Biochem. Biophys. Res. Commun. 247: 443-446.
25. Slater, T. F., and B. C. Sawyer. 1971. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem. J. 123: 823-828.
26. Ferre, N., J. Camps, E. Prats, E. Vilella, A. Paul, L. Figuera, and J. Joven. 2002. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin. Chem. 48: 261-268.
27. Pfaffl, M. W., G. W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30: e36.
28. Pfaffl, M. W., A. Tichopad, C. Prgomet, and T. P. Neuvians. 2004. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26: 509-515.
29. Wakatsuki, A., and Y. Sagara. 1995. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet. Gynecol. 85: 523-528.
30. Moorthy, K., U. C. Yadav, A. K. Mantha, S. M. Cowsik, D. Sharma, S. F. Basir, and N. Z. Baquer. 2004. Estradiol and progesterone treatments change the lipid profile in naturally menopausal rats from different age groups. Biogerontology. 5: 411-419.
31. bin Ali, A., Q. Zhang, Y. K. Lim, D. Fang, L. Retnam, and S. K. Lim. 2003. Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation. Free Radic. Biol. Med. 34: 824-829.
32. Mackness, M. I., S. Arrol, C. Abbott, and P. N. Durrington. 1993. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104: 129-135.
33. Milochevitch, C., and A. Khalil. 2001. Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging. Prostaglandins Leukot. Essent. Fatty Acids. 65: 241-246.
34. Seres, I., G. Paragh, E. Deschene, T. Fulop, Jr., and A. Khalil. 2004. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol. 39: 59-66.
35. Jaouad, L., C. de Guise, H. Berrougui, M. Cloutier, M. Isabelle, T. Fulop, H. Payette, and A. Khalil. 2006. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis. 185: 191-200.
36. Marques-Vidal, P., J. B. Ruidavets, J. P. Cambou, F. Cambien, H. Chap, and B. Perret. 1995. Distribution, fatty acid composition and apolipoprotein A-I immunoreactivity of high density lipoprotein subfractions in myocardial infarction. Atherosclerosis. 112: 29-38.
37. Barter, P., J. Kastelein, A. Nunn, and R. Hobbs. 2003. High density lipoproteins (HDLs) and atherosclerosis: the unanswered questions. Atherosclerosis. 168: 195-211.
38. Asayama, K., A. Miyao, and K. Kato. 1990. High-density lipoprotein (HDL), HDL2, and HDL3 cholesterol concentrations determined in serum of newborns, infants, children, adolescents, and adults by use of a micromethod for combined precipitation ultracentrifugation. Clin. Chem. 36: 129-131.
39. Stevenson, J. C., D. Crook, and I. F. Godsland. 1993. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 98: 83-90.
40. Bergmeier, C., R. Siekmeier, and W. Gross. 2004. Distribution spectrum of paraoxonase activity in HDL fractions. Clin. Chem. 50: 2309-2315.
41. Kontush, A., S. Chantepie, and M. J. Chapman. 2003. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23:1881-1888.